MAPK1 and Miyoshi myopathy: Inhibition of RAS-dependent mTORC1 activity enhanced reliance on MEK and ERK signaling in MM cells, and combinations of mTORC1 and MEK inhibitors resulted in a synthetic lethal phenotype that was profoundly toxic to RAS-dependent malignant cells.